iRhythm Technologies Inc has a consensus price target of $131.07 based on the ratings of 14 analysts. The high is $156 issued by JP Morgan on January 27, 2022. The low is $110 issued by Citigroup on December 11, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Morgan Stanley, and Wolfe Research on July 16, 2024, July 15, 2024, and June 20, 2024, respectively. With an average price target of $126.33 between Truist Securities, Morgan Stanley, and Wolfe Research, there's an implied 43.01% upside for iRhythm Technologies Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2024 | Buy Now | 51.69% | Truist Securities | David Rescott | $145 → $134 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | 47.16% | Morgan Stanley | Cecilia Furlong | $135 → $130 | Maintains | Overweight | Get Alert |
06/20/2024 | Buy Now | 30.18% | Wolfe Research | Mike Polark | → $115 | Upgrade | Peer Perform → Outperform | Get Alert |
05/03/2024 | Buy Now | 38.1% | Canaccord Genuity | William Plovanic | $133 → $122 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | 56.21% | Needham | David Saxon | $137 → $138 | Maintains | Buy | Get Alert |
02/23/2024 | Buy Now | 50.55% | JP Morgan | Allen Gong | $142 → $133 | Maintains | Overweight | Get Alert |
02/23/2024 | Buy Now | 50.55% | Canaccord Genuity | William Plovanic | $121 → $133 | Maintains | Buy | Get Alert |
02/23/2024 | Buy Now | 55.08% | Needham | David Saxon | $136 → $137 | Maintains | Buy | Get Alert |
01/08/2024 | Buy Now | 53.95% | Needham | David Saxon | $108 → $136 | Maintains | Buy | Get Alert |
12/22/2023 | Buy Now | 50.55% | Truist Securities | David Rescott | $115 → $133 | Maintains | Buy | Get Alert |
12/12/2023 | Buy Now | 30.18% | Truist Securities | David Rescott | $100 → $115 | Maintains | Buy | Get Alert |
12/11/2023 | Buy Now | 24.52% | Citigroup | Joanne Wuensch | → $110 | Upgrade | Neutral → Buy | Get Alert |
11/03/2023 | Buy Now | 22.25% | Needham | David Saxon | $140 → $108 | Maintains | Buy | Get Alert |
10/11/2023 | Buy Now | 52.82% | Morgan Stanley | Cecilia Furlong | $149 → $135 | Maintains | Overweight | Get Alert |
08/28/2023 | Buy Now | 31.31% | Canaccord Genuity | William Plovanic | $136 → $116 | Maintains | Buy | Get Alert |
08/07/2023 | Buy Now | 56.21% | Truist Securities | Richard Newitter | $155 → $138 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 68.67% | Morgan Stanley | Cecilia Furlong | $149 → $149 | Reiterates | Overweight → Overweight | Get Alert |
08/04/2023 | Buy Now | 47.16% | Needham | David Saxon | $151 → $130 | Maintains | Buy | Get Alert |
07/19/2023 | Buy Now | 47.16% | Baird | Mike Polark | → $130 | Initiates | → Outperform | Get Alert |
07/11/2023 | Buy Now | 68.67% | Morgan Stanley | Cecilia Furlong | $149 → $149 | Reiterates | Overweight → Overweight | Get Alert |
06/08/2023 | Buy Now | 58.48% | BTIG | Marie Thibault | $165 → $140 | Maintains | Buy | Get Alert |
06/07/2023 | Buy Now | 41.5% | Oppenheimer | Suraj Kalia | $166 → $125 | Maintains | Outperform | Get Alert |
06/07/2023 | Buy Now | 73.19% | Canaccord Genuity | William Plovanic | → $153 | Reiterates | Buy → Buy | Get Alert |
06/07/2023 | Buy Now | 30.18% | Citigroup | Joanne Wuensch | $135 → $115 | Maintains | Neutral | Get Alert |
05/05/2023 | Buy Now | 68.67% | Morgan Stanley | Cecilia Furlong | $130 → $149 | Maintains | Overweight | Get Alert |
05/05/2023 | Buy Now | 75.46% | Truist Securities | Richard Newitter | $154 → $155 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | 52.82% | Citigroup | Joanne Wuensch | $130 → $135 | Maintains | Neutral | Get Alert |
05/05/2023 | Buy Now | 70.93% | Needham | David Saxon | $133 → $151 | Maintains | Buy | Get Alert |
04/17/2023 | Buy Now | 92.44% | BTIG | Marie Thibault | $168 → $170 | Maintains | Buy | Get Alert |
04/17/2023 | Buy Now | 74.33% | Truist Securities | David Rescott | $137 → $154 | Maintains | Buy | Get Alert |
04/03/2023 | Buy Now | 47.16% | Citigroup | Joanne Wuensch | $110 → $130 | Maintains | Neutral | Get Alert |
02/24/2023 | Buy Now | 61.87% | Canaccord Genuity | William Plovanic | $135 → $143 | Maintains | Buy | Get Alert |
02/24/2023 | Buy Now | 47.16% | Morgan Stanley | Cecilia Furlong | $128 → $130 | Maintains | Overweight | Get Alert |
02/24/2023 | Buy Now | 50.55% | Needham | David Saxon | $140 → $133 | Maintains | Buy | Get Alert |
02/07/2023 | Buy Now | 69.8% | Wells Fargo | Nathan Treybeck | → $150 | Initiates | → Overweight | Get Alert |
01/06/2023 | Buy Now | 44.89% | Morgan Stanley | Cecilia Furlong | $165 → $128 | Maintains | Overweight | Get Alert |
12/20/2022 | Buy Now | 73.19% | Truist Securities | David Rescott | $167 → $153 | Maintains | Buy | Get Alert |
12/12/2022 | Buy Now | 24.52% | Citigroup | Joanne Wuensch | $144 → $110 | Maintains | Neutral | Get Alert |
11/02/2022 | Buy Now | 63.01% | Citigroup | Joanne Wuensch | $147 → $144 | Maintains | Neutral | Get Alert |
11/02/2022 | Buy Now | 58.48% | Needham | David Saxon | $185 → $140 | Maintains | Buy | Get Alert |
10/17/2022 | Buy Now | 89.04% | Truist Securities | David Rescott | $185 → $167 | Maintains | Buy | Get Alert |
10/11/2022 | Buy Now | 86.78% | Morgan Stanley | Cecilia Furlong | $172 → $165 | Maintains | Overweight | Get Alert |
09/22/2022 | Buy Now | 94.7% | Morgan Stanley | Cecilia Furlong | $190 → $172 | Maintains | Overweight | Get Alert |
09/22/2022 | Buy Now | 115.08% | JP Morgan | Allen Gong | $185 → $190 | Maintains | Overweight | Get Alert |
09/02/2022 | Buy Now | 124.13% | Canaccord Genuity | William Plovanic | $185 → $198 | Maintains | Buy | Get Alert |
08/05/2022 | Buy Now | 101.49% | BTIG | Marie Thibault | $155 → $178 | Maintains | Buy | Get Alert |
06/24/2022 | Buy Now | 75.46% | BTIG | Marie Thibault | $180 → $155 | Maintains | Buy | Get Alert |
06/22/2022 | Buy Now | 52.82% | JP Morgan | Allen Gong | $183 → $135 | Maintains | Overweight | Get Alert |
06/16/2022 | Buy Now | 86.78% | Truist Securities | David Rescott | $200 → $165 | Maintains | Buy | Get Alert |
06/09/2022 | Buy Now | 75.46% | Citigroup | Joanne Wuensch | $180 → $155 | Downgrade | Buy → Neutral | Get Alert |
05/06/2022 | Buy Now | 103.76% | Citigroup | Joanne Wuensch | $175 → $180 | Maintains | Buy | Get Alert |
05/06/2022 | Buy Now | 115.08% | Morgan Stanley | Cecilia Furlong | $151 → $190 | Maintains | Overweight | Get Alert |
05/06/2022 | Buy Now | 102.63% | Needham | David Saxon | $135 → $179 | Maintains | Buy | Get Alert |
04/06/2022 | Buy Now | 18.86% | Wolfe Research | Mike Polark | → $105 | Initiates | → Underperform | Get Alert |
04/04/2022 | Buy Now | 117.34% | JP Morgan | Allen Gong | $156 → $192 | Maintains | Overweight | Get Alert |
02/24/2022 | Buy Now | 70.93% | Morgan Stanley | Cecilia Furlong | $167 → $151 | Maintains | Overweight | Get Alert |
02/24/2022 | Buy Now | 52.82% | Needham | David Saxon | → $135 | Upgrade | Hold → Buy | Get Alert |
01/27/2022 | Buy Now | 76.59% | JP Morgan | Robbie Marcus | $116 → $156 | Maintains | Overweight | Get Alert |
01/18/2022 | Buy Now | 89.04% | Morgan Stanley | Cecilia Furlong | $129 → $167 | Upgrade | Equal-Weight → Overweight | Get Alert |
01/14/2022 | Buy Now | 86.78% | Citigroup | Joanne Wuensch | $120 → $165 | Maintains | Buy | Get Alert |
01/14/2022 | Buy Now | 81.12% | Canaccord Genuity | William Plovanic | $125 → $160 | Maintains | Buy | Get Alert |
01/12/2022 | Buy Now | 92.44% | BTIG | Marie Thibault | → $170 | Upgrade | Neutral → Buy | Get Alert |
01/11/2022 | Buy Now | 69.8% | Oppenheimer | Suraj Kalia | → $150 | Upgrade | Perform → Outperform | Get Alert |
01/07/2022 | Buy Now | 46.03% | Morgan Stanley | Cecilia Furlong | $114 → $129 | Maintains | Equal-Weight | Get Alert |
12/17/2021 | Buy Now | 31.31% | JP Morgan | Robbie Marcus | — | Upgrade | Neutral → Overweight | Get Alert |
12/15/2021 | Buy Now | 35.84% | Citigroup | Joanne Wuensch | — | Upgrade | Neutral → Buy | Get Alert |
11/08/2021 | Buy Now | 29.05% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
The latest price target for iRhythm Technologies (NASDAQ:IRTC) was reported by Truist Securities on July 16, 2024. The analyst firm set a price target for $134.00 expecting IRTC to rise to within 12 months (a possible 51.69% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for iRhythm Technologies (NASDAQ:IRTC) was provided by Truist Securities, and iRhythm Technologies maintained their buy rating.
The last upgrade for iRhythm Technologies Inc happened on June 20, 2024 when Wolfe Research raised their price target to $115. Wolfe Research previously had a peer perform for iRhythm Technologies Inc.
The last downgrade for iRhythm Technologies Inc happened on June 9, 2022 when Citigroup changed their price target from $180 to $155 for iRhythm Technologies Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iRhythm Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iRhythm Technologies was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
While ratings are subjective and will change, the latest iRhythm Technologies (IRTC) rating was a maintained with a price target of $145.00 to $134.00. The current price iRhythm Technologies (IRTC) is trading at is $88.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.